News📰: Gilead Buys Forty Seven for $ 4.9 bn

Gilead Sciences Inc. (which shares I currently own) will likely buy Forty Seven Inc. for c. 4.9 bn USD* or $ 95.50 per Share, representing a premium of 96% to the Thursday closing price.

Forty Seven is active in researching cancer treatments that make use of the immune system against tumors.

*) including some other instruments than cash

2 thoughts on “News📰: Gilead Buys Forty Seven for $ 4.9 bn

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s